SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
子车谷波
Lv2
156 积分
2021-08-08 加入
最近求助
最近应助
互助留言
It is time to rethink clinical trials on Bruton's tyrosine kinase inhibitors in multiple sclerosis
2天前
已完结
Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances
5天前
已完结
Bruton tyrosine kinase inhibitors in multiple sclerosis: evidence and expectations
5天前
已完结
P-Glycoprotein (MDR1/ABCB1) Restricts Brain Penetration of the Bruton’s Tyrosine Kinase Inhibitor Ibrutinib, While Cytochrome P450-3A (CYP3A) Limits Its Oral Bioavailability
5天前
已完结
Bruton’s tyrosine kinase inhibitors in Refractory or Relapsing Primary Central Nervous System Lymphoma: A meta-analysis and systematic review
5天前
已完结
Bruton’s tyrosine kinase (BTK) inhibitors for the treatment of primary central nervous system lymphoma (PCNSL): current progress and latest advances
10天前
已完结
Discovery of Potent and Highly Selective Interleukin-2-Inducible T-Cell Kinase Degraders with In Vivo Activity
18天前
已完结
Degrading the signal amplifier: ITK as a target for targeted protein degradation
19天前
已完结
Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview
1个月前
已完结
Fast, instrument-free and low-cost selection of high-affinity aptamers
1个月前
已完结
没有进行任何应助
点赞
2天前
点赞
5天前
点赞
5天前
速度真快
5天前
点赞
5天前
速度真快
10天前
速度真快
1个月前
速度真快
1个月前
速度真快
1个月前
速度真快
1个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论